This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: University of California. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Jerry C Hu: Innovator in Tissue Engineering
Introduction
Jerry C Hu is a prominent inventor based in Irvine, California. He has made significant contributions to the field of tissue engineering, particularly in the development of methods for conserving highly expanded cells. His innovative work has the potential to revolutionize the creation of neocartilage, which is essential for various medical applications.
Latest Patents
Jerry C Hu holds a patent for "Methods and systems for conserving highly expanded cells." This patent describes processes that enable the conservation of highly expanded chondrocytes, which can be utilized to construct neocartilage with functional properties similar to native articular cartilage. The methods outlined in the patent allow for the production of engineered cartilage implants from a minimal number of cells, specifically those expanded to at least 1.5×10 or P3 or greater. This advancement is crucial for the future of regenerative medicine.
Career Highlights
Jerry C Hu is affiliated with the University of California, where he continues to engage in groundbreaking research. His work focuses on the intersection of cell biology and tissue engineering, aiming to create functional human cartilage that can be used in medical treatments.
Collaborations
Throughout his career, Jerry has collaborated with notable colleagues, including Kyriacos A Athanasiou and Heenam Kwon. These partnerships have further enhanced the impact of his research and innovations in the field.
Conclusion
In summary, Jerry C Hu is a key figure in the advancement of tissue engineering, with a focus on conserving highly expanded cells for neocartilage production. His contributions are paving the way for innovative solutions in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
